SCHEMBL12848675

SCHEMBL12848675

O=Nc1ccc(N2CCCCCC2)c(F)c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
MAPT P10636 7/20 0.50
HPGD P15428 3/20 0.50
TSHR P16473 2/20 0.50
RAB9A P51151 4/20 0.48
NPC1 O15118 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HTT P42858 2/20 0.46
MITF O75030 1/20 0.46
HSP90AA1 P07900 1/20 0.46
GAA P10253 1/20 0.44
SLC6A9 P48067 1/20 0.41
MAPK1 P28482 1/20 0.41
IP6K1 Q92551 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8736858 0.83 MAPT (0.43) ALDH1A1SMN1; SMN2MAPTGAA
SCHEMBL12128903 0.83 HPGD (0.52) ALDH1A1SMN1; SMN2MAPTHPGDTSHR
SCHEMBL29037852 0.83 KDM4E (0.50) ALDH1A1SMN1; SMN2MAPTRAB9ANPC1
SCHEMBL12464187 0.80 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2MAPTHPGDTSHR
SCHEMBL14311448 0.79 PARP1 (0.41) ALDH1A1SMN1; SMN2HPGDGAA
SCHEMBL29891888 0.76 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2MAPTHPGDTSHR
SCHEMBL6441668 0.76 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2MAPTHPGDTSHR
SCHEMBL10157382 0.75 ALDH1A1 (0.44) ALDH1A1GAA
SCHEMBL5715714 0.74 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2MAPTHPGDTSHR
SCHEMBL13816038 0.73 MAPT (0.42) ALDH1A1SMN1; SMN2MAPTKMT2ASLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906516-B2 Carbonyl compounds MERCK PATENT GMBH (DE) 2011-03-15 US disclosed
US-20080081814-A1 Carbonyl Compounds Which Can be Used as Inhibitors of Coagulation Factor Xa CEZANNE BERTRAM 2008-04-03 US disclosed
US-20080003214-A1 Medicaments Comprising Carbonyl Compounds, And The Use Thereof MERCK PATENT GMBH (DE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081814-A1 Carbonyl Compounds Which Can be Used as Inhibitors of Coagulation Factor Xa F2, F11, F12 ALDH1A1 593/4885SMN1; SMN2 3401/4885MAPT 4368/4885
US-20080003214-A1 Medicaments Comprising Carbonyl Compounds, And The Use Thereof F2, PDHX, SDHB ALDH1A1 339/4885SMN1; SMN2 3650/4885MAPT 2660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.